GLP-1 Weight Loss — The Science-Backed Protocol That Changes Body Composition
Quick Answer
GLP-1 receptor agonists (semaglutide and tirzepatide) are the most effective weight loss medications available. In clinical trials, tirzepatide produced 21% average body weight reduction; semaglutide produced 15%. Both work by suppressing appetite, slowing gastric emptying, and improving insulin sensitivity.
GLP-1 (glucagon-like peptide-1) receptor agonists have fundamentally changed the landscape of medical weight loss. These medications work by mimicking a natural gut hormone that your body already produces, amplifying the signals that control appetite, satiety, and metabolic function. The result: consistent, significant weight loss that was previously only achievable through bariatric surgery.
How GLP-1 works mechanically
After you eat, your gut releases GLP-1 — a hormone that signals your brain to feel full, tells your stomach to slow down digestion, and helps your pancreas regulate blood sugar. The problem is that natural GLP-1 breaks down within minutes. Medications like semaglutide and tirzepatide are engineered versions of this hormone that last much longer, allowing once-weekly dosing.
GLP-1 receptor agonists work through three primary mechanisms: appetite suppression (acting on hypothalamic hunger centers to reduce caloric intake by 20-30%), delayed gastric emptying (food stays in your stomach longer, extending the feeling of fullness), and improved insulin sensitivity (better glucose regulation reduces fat storage and cravings). These effects combine to produce sustained, meaningful weight loss.
Semaglutide vs tirzepatide
Both medications are GLP-1 receptor agonists, but they work differently. Semaglutide activates one receptor (GLP-1). Tirzepatideactivates two (GLP-1 + GIP), making it a “twincretin.” The dual mechanism produces greater average weight loss and may offer better tolerability for some patients.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) |
| Avg weight loss | ~15% | ~21% |
| Key trial | STEP 1 (NEJM 2021) | SURMOUNT-1 (NEJM 2022) |
| Marrow price | $249/mo | $339/mo |
| Best for | First-time GLP-1, budget | Max results, plateaus |
Who qualifies
GLP-1 medications may be appropriate for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (such as high blood pressure, type 2 diabetes, or high cholesterol). At Marrow, a licensed physician evaluates your health history, current medications, and goals during your intake to determine if GLP-1 therapy is appropriate.
Marrow also offers microdosing protocols for patients with lower BMIs who are focused on metabolic optimization and body composition rather than significant weight loss.
What to expect week-by-week
Weeks 1-4: Adjustment
You start at the lowest dose to minimize side effects. Most patients notice reduced appetite and smaller portion sizes within the first 1-2 weeks. Mild nausea is common but typically manageable. Weight loss of 2-5 pounds is typical during this phase. Focus on hydration and high-protein meals.
Weeks 5-8: Acceleration
Your physician increases the dose based on tolerability. Appetite suppression becomes more pronounced. Most patients are losing 1-2 pounds per week consistently. GI side effects typically resolve. This is when the medication “clicks” for most patients — food noise quiets significantly, and eating patterns shift naturally.
Months 3-6: Steady state
You reach a therapeutic dose and weight loss continues at a consistent pace. Most patients have lost 8-15% of body weight by month 6. Energy improves, metabolic markers (blood sugar, cholesterol, blood pressure) typically improve. Your physician may adjust dosing based on progress and goals. This is the window where building sustainable habits — strength training, protein intake — pays the biggest dividends.
Muscle preservation protocol
One of the most important considerations with any significant weight loss is preserving lean muscle mass. Rapid weight loss without resistance training can result in losing muscle along with fat, which lowers your metabolic rate and compromises long-term results.
Marrow recommends a muscle preservation protocol alongside GLP-1 therapy: protein intake of 1g per pound of bodyweight daily, resistance training 2-3 times per week, and adequate hydration. Studies show that combining GLP-1 medications with resistance training preserves significantly more lean mass compared to medication alone. Your Marrow physician can help tailor this protocol to your fitness level and goals.
Marrow pricing
Semaglutide
$249/mo
15% avg weight loss
Tirzepatide
$339/mo
21% avg weight loss
Both plans include medication from an FDA-registered 503B pharmacy, physician oversight, all injection supplies, dosage adjustments, and free shipping. No insurance required. No hidden fees.
View full pricing details or compare weight loss treatments.
Frequently asked questions
Is GLP-1 safe?
Yes. Both semaglutide and tirzepatide have been extensively studied in large-scale clinical trials involving tens of thousands of participants. The most common side effects — nausea, constipation, and diarrhea — are typically mild and resolve within 2-4 weeks as your body adjusts. Serious side effects are rare. At Marrow, a licensed physician monitors you throughout treatment and adjusts dosing based on your response.
How much weight will I lose?
Results vary by individual and medication. In clinical trials, semaglutide produced an average of 15% body weight reduction over 68 weeks (STEP 1 trial), while tirzepatide produced 21% average reduction over 72 weeks (SURMOUNT-1 trial). For someone starting at 230 pounds, that's roughly 34-48 pounds. Your Marrow physician sets realistic expectations based on your starting weight, health history, and goals.
Do I need to exercise?
Exercise is not required for GLP-1 medications to produce weight loss — the clinical trials did not mandate exercise programs. However, resistance training significantly improves outcomes by preserving lean muscle mass during weight loss. Marrow recommends strength training 2-3 times per week and a high-protein diet (1g per pound of bodyweight) for optimal body composition changes.
What happens when I stop GLP-1?
Studies show that weight regain is common after discontinuing GLP-1 medications, particularly without lifestyle changes. The STEP 1 extension trial found that participants regained approximately two-thirds of lost weight within one year of stopping semaglutide. This is why Marrow emphasizes building sustainable habits — protein intake, resistance training, and metabolic health — alongside medication.
Does insurance cover GLP-1?
Most insurance plans do not cover GLP-1 medications for weight loss, and brand-name versions cost $900-1,400/month out of pocket. Compounded versions through Marrow start at $249/mo for semaglutide and $339/mo for tirzepatide — no insurance required. This includes physician oversight, all supplies, and free shipping.
Start GLP-1 weight loss from $249/mo
Semaglutide or tirzepatide. Physician review within 24 hours. Ships to your door.
Start your intake →